Geert Goderis

Prof. Geert Goderis

Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2016 in Diabetic Medicine
Verified
Journal Article
Closed access
PDF file
IOI. Odnoletkova
I. Odnoletkova
Geert GoderisGeert Goderis
Geert Goderis
FNF. Nobels
F. Nobels
SFS. Fieuws
S. Fieuws
BAB. Aertgeerts
B. Aertgeerts
DRD. Ramaekers
D. Ramaekers

6 June 2014 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
CTCarla Truyers
Carla Truyers
Geert GoderisGeert Goderis
Geert Goderis
HDHarrie Dewitte
Harrie Dewitte
Marjan van den AkkerMarjan van den Akker
Marjan van den Akker
FBFrank Buntinx
Frank Buntinx
Intego is the only operational computerized morbidity registration network in Belgium based on general practice data. Intego collects data from over 90 general practitioners. All the information is routinely collected in the electronic health record during daily practice.

12 February 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Marjan van den AkkerMarjan van den Akker
Marjan van den Akker
BVBert Vaes
Bert Vaes
Geert GoderisGeert Goderis
Geert Goderis
GPGijs Van Pottelbergh
Gijs Van Pottelbergh
TBTine De Burghgraeve
Tine De Burghgraeve
SHSéverine Henrard
Séverine Henrard
The aim of this paper was to describe the time trends in the prevalence of multimorbidity and polypharmacy in Flanders (Belgium) between 2000 and 2015, while controlling for age and sex. Data were available from Intego, a Flemish-Belgian general practice-based morbidity registration network. The practice population between 2000 and 2015 was used as the denominator, representing a mean of 159,946 people per year. Age and gender-standardised prevalence rates were used for the trends of multimorbidity and polypharmacy in the total population and for subgroups. Joinpoint regression analyses were used to analyse the time trends and breaks in trends, for the entire population as well as for specific age and sex groups. Overall, in 2015, 22.7% of the population had multimorbidity, while the overall prevalence of polypharmacy was 20%. Throughout the study period the standardised prevalence rate of multimorbidity rose for both sexes and in all age groups. The largest relative increase in multimorbidity was observed in the younger age groups (up to the age of 50 years). The prevalence of polypharmacy showed a significant increase between 2000 and 2015 for all age groups except the youngest (0–25 years). For all adult age groups multimorbidity and polypharmacy are frequent, dynamic over time and increasing. This asks for both epidemiological and interventional studies to improve the management of the resulting complex care.

2 January 2017 in Scandinavian Journal of Primary Health Care
Verified
Journal Article
Open access
MTMia Tyrstrup
Mia Tyrstrup
AVAlike van der Velden
Alike van der Velden
SESven Engstrom
Sven Engstrom
Geert GoderisGeert Goderis
Geert Goderis
SMSigvard Molstad
Sigvard Molstad
NANiels Adriaenssens
Niels Adriaenssens
Objective: To assess the quality of antibiotic prescribing in primary care in Belgium, the Netherlands and Sweden using European disease-specific antibiotic prescribing quality indicators (APQI) and taking into account the threshold to consult and national guidelines. Design: A retrospective observational database study. Setting: Routine primary health care registration networks in Belgium, the Netherlands and Sweden. Subjects: All consultations for one of seven acute infections [upper respiratory tract infection (URTI), sinusitis, tonsillitis, otitis media, bronchitis, pneumonia and cystitis] and the antibiotic prescriptions in 2012 corresponding to these diagnoses. Main outcome measures: Consultation incidences for these diagnoses and APQI values (a) the percentages of patients receiving an antibiotic per diagnosis, (b) the percentages prescribed first-choice antibiotics and (c) the percentages prescribed quinolones. Results: The consultation incidence for respiratory tract infection was much higher in Belgium than in the Netherlands and Sweden. Most of the prescribing percentage indicators (a) were outside the recommended ranges, with Belgium deviating the most for URTI and bronchitis, Sweden for tonsillitis and the Netherlands for cystitis. The Netherlands and Sweden prescribed the recommended antibiotics (b) to a higher degree and the prescribing of quinolones exceeded the proposed range for most diagnoses (c) in Belgium. The interpretation of APQI was found to be dependent on the consultation incidences. High consultation incidences were associated with high antibiotic prescription rates. Taking into account the recommended treatments from national guidelines improved the results of the APQI values for sinusitis in the Netherlands and cystitis in Sweden. Conclusion: Quality assessment using European disease-specific APQI was feasible and their inter-country comparison can identify opportunities for quality improvement. Their interpretation, however, should take consultation incidences and national guidelines into account. Differences in registration quality might limit the comparison of diagnosis-linked data between countries, especially for conditions such as cystitis where patients do not always see a clinician before treatment.

1 April 2022 in International Journal of Integrated Care
Verified
Journal Article
Open access
PDF file
MLMerel Leithaus
Merel Leithaus
ABAudrey Beaulen
Audrey Beaulen
EVErica De Vries
Erica De Vries
Geert GoderisGeert Goderis
Geert Goderis
JFJohan Flamaing
Johan Flamaing
MDMieke Deschodt
Mieke Deschodt
Frail older adults frequently experience transitions from hospital to home due to their complex care needs. Transitional care models (TCMs) are recommended to tackle adverse outcomes in frail patients. This review summarizes the use of integrated care components in addressing transitional care from hospital to home, provides an overview on reported outcomes and describes the impact of identified components on the outcomes hospital readmission and emergency department visit. This study is part of the European TRANS-SENIOR project. PubMed, CINAHL and Embase were searched for studies in English, German and Dutch that describe a TCM for frail older patients including both pre- and post-discharge components. Seventeen studies, covering 15 TCMs were included. All TCMs describe a person-centred, tailored, pro-active and continuous transitional care service. Components like a small sized care team, intensive follow-up, shared decision making and informal caregiver involvement are likely to be associated with reduced hospital readmission and ED visits. Twenty-seven transitional care outcomes were reported: 19 service outcomes, six patient outcomes and two provider outcomes. Heterogeneity in content and outcomes complicates between-study comparison, yet several components were identified that improved care outcomes. Patient and provider outcomes should be included in future research.

7 January 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
MSMiek Smeets
Miek Smeets
BVBert Vaes
Bert Vaes
PMPavlos Mamouris
Pavlos Mamouris
Marjan van den AkkerMarjan van den Akker
Marjan van den Akker
GPGijs Van Pottelbergh
Gijs Van Pottelbergh
SHSéverine Henrard
Séverine Henrard
Objectives To assess the prevalence and incidence of heart failure (HF) stages A to C/D and their evolution over a 16-year period. Additionally, trends in comorbidities and cardiovascular (CV) treatment in patients with HF were studied in the same period. Design Registry-based study. Setting Primary care, Flanders, Belgium. Participants Data were obtained from Intego, a morbidity registration network in which 111 general practitioners of 48 practices collaborate. In the study period between 2000 and 2015, data from 165 796 unique patients aged 45 years and older were available. Outcome measures Prevalence and incidence were calculated for HF stage A, B and C/D by gender. Additionally, the trend in age-standardised prevalence and incidence rates between 2000 and 2015 was analysed with joint-point regression. The same model was used to study trends in comorbidity profiles in incident HF cases and trends in cardiovascular medication in prevalent HF cases. Results We found a downward trend in the incidence and prevalence of HF stage C/D in Flemish general practice between 2000 and 2015, whereas the prevalence and incidence of stage A and B increased. The burden of comorbidities in incident HF cases increased during the study period, as shown by an increasing disease count (p<0.001). The prescription of cardiovascular medication such as renin-angiotensin-aldosterone system blockade, β-blockers and statins showed a sharp increase in the first part of the study period (2000–2008). Conclusion Age-standardised incidence and prevalence of HF stage C/D showed a slightly downward trend over the past 16 years, probably due to the sharp increase in cardiovascular treatment. However, the increasing age-standardised incidence and prevalence of stage A and B, as precursors of symptomatic HF, together with a rising comorbid burden, highlights the challenges we are still facing.